Linked Life Data

21243400

Source:http://linkedlifedata.com/resource/pubmed/id/21243400

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-6-9
pubmed:abstractText
Tumor necrosis factor (TNF) plays an important role in the host defense mechanism, and anti-TNF antibody therapies may increase the risk of serious infections. We herein report a case of 57-year-old male with rheumatoid arthritis who developed brucellosis during treatment with infliximab in combination with methotrexate and a low-dose steroid. Brucellosis should be kept in mind, particularly in endemic areas, in patients receiving anti-TNF therapy. Clinicians should be aware of brucellosis symptoms and ways of contamination and should warn their patients. Early diagnosis and rapid treatment may prevent a possible poor course of the disease in immunocompromised patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1439-7609
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
313-5
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Infliximab and brucellosis: not the usual suspects, this time.
pubmed:affiliation
Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Gevher Nesibe Hospital, Erciyes University, Romatoloji BD, 38039 Kayseri, Turkey.
pubmed:publicationType
Journal Article, Case Reports